Jump to main content
Jump to site search

Issue 101, 2015
Previous Article Next Article

Biodegradable polymer–platinum drug conjugates to overcome platinum drug resistance

Author affiliations

Abstract

Drug resistance and severe dose-dependent side effects are the major obstacles to the further use of platinum agents. Two well-acknowledged mechanisms of resistance are the decreased intracellular accumulation and the increased sulfur-binding-detoxification of platinum agents. The polymer–drug conjugate approach can remarkably enhance the uptake of substances by cancer cells, therefore can achieve better anticancer effects with lower dosage, and thus reduce the dose-dependent side effects. Here we synthesized a biodegradable polymer containing pendant 1,2-bidentate carboxyl groups to chelate platinum without introducing sulfur atoms to potentially detoxify the platinum drugs. The polymer–platinum conjugate formed nanomicelles showed significantly increased intracellular accumulation and could partially overcome drug resistance in ovarian cancer cells.

Graphical abstract: Biodegradable polymer–platinum drug conjugates to overcome platinum drug resistance

Back to tab navigation

Supplementary files

Publication details

The article was received on 13 Jun 2015, accepted on 23 Sep 2015 and first published on 23 Sep 2015


Article type: Paper
DOI: 10.1039/C5RA11297D
Author version
available:
Download author version (PDF)
Citation: RSC Adv., 2015,5, 83343-83349
  •   Request permissions

    Biodegradable polymer–platinum drug conjugates to overcome platinum drug resistance

    Q. Yang, R. Qi, J. Cai, X. Kang, S. Sun, H. Xiao, X. Jing, W. Li and Z. Wang, RSC Adv., 2015, 5, 83343
    DOI: 10.1039/C5RA11297D

Search articles by author

Spotlight

Advertisements